Previous close | 4.1000 |
Open | N/A |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 640.00 |
Expiry date | 2022-10-21 |
Day's range | N/A - N/A |
Contract range | N/A |
Volume | |
Open interest | 20 |
Every investor in IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) should be aware of the most powerful shareholder groups...
Participating in the call this morning are Jay Mazelsky, president and chief executive officer; Brian McKeon, chief financial officer; and John Ravis, vice president, investor relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements.
IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.